Choi Joon Young, Jang Hong-Ju, Shim Young Mog, Kim Kwhanmien, Lee Kyung Soo, Lee Kyung-Han, Choi Yong, Choe Yearn Seong, Kim Byung-Tae
Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 135-710, Korea.
J Nucl Med. 2004 Nov;45(11):1843-50.
We investigated whether the standardized uptake value (SUV) of the primary tumor, the tumor length measured on a PET image, the number of (18)F-FDG PET-positive nodes, and the PET stage were independent prognostic predictors over other clinical variables in patients with esophageal squamous cell carcinoma who were undergoing curative surgery.
Sixty-nine patients with newly diagnosed esophageal squamous cell carcinoma who underwent preoperative (18)F-FDG PET and curative esophagectomy were included. The events for survival analysis were defined as recurrence or metastasis and cancer-related death. The disease-free and overall survival rates of each variable were estimated by the Kaplan-Meier method. The Cox proportional hazards model was used to evaluate independent prognostic variables for multivariate survival analysis.
Using univariate survival analysis, the presence of adjuvant therapy, pathologic stage, number of CT-positive nodes (0, 1, > or =2), tumor length on PET (cutoff: 3 cm, 5 cm), number of PET-positive nodes (0, 1, 2, > or =3), and PET stage (N0 M0, N1 M0, M1) were significant prognostic predictors for disease-free survival. However, only the number of PET-positive nodes was an independent significant prognostic predictor for disease-free survival in multivariate analysis (hazard ratio = 1.87, P < 0.001). In univariate survival analysis, the sex, presence of adjuvant therapy, clinical and pathologic stages, number of CT-positive nodes, maximum SUV of the primary tumor (cutoff: 6.3, 13.7), tumor length on PET, number of PET-positive nodes, and PET stage were significant prognostic predictors for overall survival. In contrast, the clinical stage (hazard ratio = 0.53, P < 0.05), pathologic stage (hazard ratio = 3.14, P < 0.005), tumor length by PET (hazard ratio = 2.74, P = 0.01), and number of PET-positive nodes (hazard ratio = 1.71, P < 0.05) were independent significant prognostic predictors for overall survival in multivariate analysis.
In addition to the pathologic stage, (18)F-FDG PET provides noninvasively independent prognostic information using the number of positive lymph nodes and the tumor length on the PET image in preoperative esophageal squamous cell carcinoma. A revised TNM classification system for esophageal carcinoma may consider tumor length and the number of positive lymph nodes as important prognostic factors.
我们研究了在接受根治性手术的食管鳞状细胞癌患者中,原发肿瘤的标准化摄取值(SUV)、PET图像上测量的肿瘤长度、(18)F-FDG PET阳性淋巴结数量以及PET分期相对于其他临床变量是否为独立的预后预测指标。
纳入69例新诊断的食管鳞状细胞癌患者,这些患者接受了术前(18)F-FDG PET检查及根治性食管切除术。生存分析的事件定义为复发或转移以及癌症相关死亡。采用Kaplan-Meier法估计各变量的无病生存率和总生存率。使用Cox比例风险模型评估多因素生存分析中的独立预后变量。
单因素生存分析显示,辅助治疗的存在、病理分期、CT阳性淋巴结数量(0、1、≥2)、PET上的肿瘤长度(截断值:3 cm、5 cm)、PET阳性淋巴结数量(0、1、2、≥3)以及PET分期(N0 M0、N1 M0、M1)是无病生存的显著预后预测指标。然而,多因素分析中仅PET阳性淋巴结数量是无病生存的独立显著预后预测指标(风险比=1.87,P<0.001)。单因素生存分析中,性别、辅助治疗的存在、临床和病理分期、CT阳性淋巴结数量、原发肿瘤的最大SUV(截断值:6.3、13.7)、PET上的肿瘤长度、PET阳性淋巴结数量以及PET分期是总生存的显著预后预测指标。相比之下,多因素分析中临床分期(风险比=0.53,P<0.05)、病理分期(风险比=3.14,P<0.005)、PET测量的肿瘤长度(风险比=2.74,P=0.01)以及PET阳性淋巴结数量(风险比=1.71,P<0.05)是总生存的独立显著预后预测指标。
除病理分期外,(18)F-FDG PET利用术前食管鳞状细胞癌PET图像上的阳性淋巴结数量和肿瘤长度提供非侵入性的独立预后信息。修订后的食管癌TNM分类系统可能将肿瘤长度和阳性淋巴结数量视为重要的预后因素。